MassDevice.com +5 | The top 5 medtech stories for September 30, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Sunshine Heart shifts focus to Aquadex FlexFlow system Sunshine Heart said today it will realign its strategy to focus on its recently acquired Aquadex FlexFlow system, designed to filter water and salt from patients with fluid overload due to renal failure. The Eden Prairie, Minn.-based company acquired the system from Baxter for $5 million in August this year. It also said it will pause clinical evaluations of its neuromodulation tech and reduce cash burn to $80,000 per month in the 4th quarter of 2016. Read more 4. Mergers, IP, risk assessment among trends in medtech In 1995, the average time to a successful exit for a medical device startup was about 3 years, according to Rotational Medical CEO Martha Shadan. Now, Shadan said, it can range from 6 to 9 years and cost as much as $50 million. Shadan suggested that the increase in exit time is probably due to risk associated with investing in medtech and a lack of venture capitalists. “This is a real problem for the industry,” Shadan said this week at MassDevice.com’s 5th annual DeviceTalks Boston event, ...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news